Skip to content

Common Stock at other companies

Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
300M0.0%
BridgeBio Pharma logo
BridgeBio PharmaBBIO
500M+253,707%
Madrigal Pharmaceuticals, Inc. logo
Madrigal Pharmaceuticals, Inc.MDGL
200M0.0%
AbbVie logo
AbbVieABBV
$18M0.0%
Revvity logo
RevvityRVTY
300M0.0%
ALN
Alnylam PharmaceuticalsALNY

Other financials

Income statement

See full
Revenue$73.7M-86.4%
Operating income-$141.3M-137%
Net income-$132.7M-136%
EPS (diluted)-$0.93-134%

Balance sheet

See full
Cash & equivalents$188.5M+1.5%
Total debt$107.9M-5.6%
Total equity$614.0M-10.1%
Total assets$2.3B+44.2%

Cash flow

See full
Operating cash flow$84.4M-81.6%
CapEx$2.6M-51.6%
Free cash flow$81.9M-82.0%

Valuation

See full
Market cap$11.52B+402%
Enterprise value$11.44B+418%
P/S18.5×+14.3×

Profitability

See full
Operating margin-35.7%+63.6pp
Net margin-48.4%+240pp
FCF margin1.8%+0.9pp

Returns & leverage

See full
Return on equity-46.4%+341pp
Debt / equity0.2×0.0×
Current ratio6.2×+1.1×

Where this comes from

Reported directly by Arrowhead Research in its filing.

Tagged under the XBRL concept us-gaap:CommonStockValue.

The official record: Arrowhead Research’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Arrowhead Research's common stock.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Arrowhead Research's common stock?
Arrowhead Research (ARWR) reported common stock of $236K in Q1 2026.
How has Arrowhead Research's common stock changed year-over-year?
Arrowhead Research's common stock increased by 2.6% year-over-year, from $230K to $236K.
What is the long-term trend for Arrowhead Research's common stock?
Over 5 years (2020 to 2025), Arrowhead Research's common stock has grown at a 3.4% compound annual growth rate (CAGR), from $195K to $231K.
What does common stock mean?
The total par value of all common shares issued by the company.
How do you interpret common stock?
Increases typically reflect capital raises through equity issuance, which dilutes existing shareholders but improves cash position.
How does common stock compare across companies?
Standard equity line item; biotech companies frequently issue common stock to fund clinical trials.